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Background: Tuberculosis (TB) remains a significant public health problem in Peru, causing an estimated 35,000
new cases each year, 6.7% of whom are co-infected with HIV. Social support mechanisms are key in influencing
health-seeking behavior, adherence, and overall patient wellbeing in clinical settings. We examine the types of
social support received by TB patients and parents of pediatric patients in peri-urban Lima, Peru, to understand its
role in patients’ psychosocial wellbeing during treatment.
Methods: Semi-structured interviews were conducted between August 2004 and May 2005 among 43 individuals: 19
adults with TB, 8 adults with TB/HIV, 13 parents of pediatric TB patients, and 3 parents of pediatric TB/HIV patients.
Results: Patients described the need for psychosocial support to mitigate the difficulty of continually going to the
clinic to take medications, tending to other family or professional responsibilities while on treatment, and confronting
stigma and social isolation within their community. Family members most often contributed to meeting these
psychosocial needs, and were also crucial in providing economic support to patients faced with burdensome medical
expenses or who were forced to leave their jobs due to being on treatment. Most healthcare personnel were
described as key providers of emotional support and encouragement for patients to successfully adhere to treatment,
however there were a select few doctors whose “scare tactics” seemingly discouraged patient adherence. During the
treatment process, patients described being more socially withdrawn as a result of feeling fatigued from their
medications, however most participants also described forming new mutually supportive friendships among their
fellow patients.
Conclusions: Despite the general reluctance of patients to disclose their disease status, patients received a significant
amount of psychosocial support from both family members to whom they disclosed, and from positive interactions
with healthcare providers. High levels of depression were reported, with many patients voicing need for improved and
more frequent psychological interventions. To improve the Peru TB program, participants suggested extending
educational opportunities to patients’ families and the wider community, increasing the existing amount of nutritional
support, and programmatic provision of vocational activities to increase economic opportunities.
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Worldwide, tuberculosis (TB) continues to be a signifi-
cant public health problem: there are an approximate
140 new cases per 100,000 population globally, and in
2009 alone, approximately 1.7 million deaths were due
to TB throughout the world [1]. TB treatment programs,
such as internationally recommended direct observed
treatment short course (DOTS), have demonstrated in-
creased adherence to medication and successful treat-
ment outcomes [2]. However some skepticism does exist
among experts who are not convinced that there is suffi-
cient data to prove its effectiveness [3]. Factors associ-
ated with poverty, such as malnutrition, overcrowding,
poor ventilation, unemployment, and lack of access to
healthcare prevent greater control of the disease in many
developing countries [4-8].
Although the population of Peru is only 3 percent of
the Americas, it bears 12 percent of the region’s TB
cases [9]. In 2007, Peru had the largest number of new
TB cases in South America and the highest reported
number of new and relapse cases of TB in South America
per 100,000 people, with approximately 35,000 cases in
total [10]. In 2006, there were 18,855 cases of TB in
Peru’s capital city of Lima alone [11]. Moreover, a sig-
nificant portion of TB patients is co-infected with HIV:
in Peru, in 2007, 2400 of the 35,000 new cases of TB
were among patients also infected with HIV [10]. Al-
though Peru has an exemplary TB program [12] and an
HIV prevalence rate of less than .5%, rates of multidrug-
resistant tuberculosis (MDR-TB) have continued to in-
crease in recent years, making Peru one of the top eight
MDR-TB burdened countries in the world [13,14]. Cases
of tuberculosis, MDR-TB, and most recently extremely
drug resistant tuberculosis (XDR-TB) are highly concen-
trated in Lima compared to the rest of Peru; from 1997 to
2007, 87% of MDR-TB cases in Peru occurred within the
capital and its surrounding areas [14,15]. In 1990, Peru’s
Ministry of Health (MINSA) integrated DOTs into the
structure of the National TB Program, requiring that
patients be observed taking their TB medications by a
healthcare professional at their respective health center.
DOTS coverage currently extends to 100% of patients
enrolled in Peru’s National TB program [16], including
all participants in this study. Peru’s National TB Pro-
gram also supplies food aid and psychological consulta-
tions to patients. Nonetheless, greater control of TB
was hindered by the increase in HIV/AIDS cases with
TB co-infection and the increased cases of multi-drug
resistant TB (MDR-TB) [2,8].
Social support has been categorized in various ways,
but overall denotes social interactions that “lead the
subject to believe that he is cared for, loved, esteemed
and a member of a network of mutual obligations” [17].
There is evidence that social support is key in influencinghealth-seeking behaviors, treatment adherence and health
outcomes [18-20]. However, there are limited studies
that examine the role of social support specifically
with regards to patients with TB, and that furthermore
outline the particular components of social support
that are helpful or harmful to such patients. This study
aims to discuss these matters within the sociocultural
context of a peri-urban sub-section of Lima, Peru.
Several studies in developing countries describe that
improved quality of care by health providers and in-
creased support from family during TB treatment can
lead to increased adherence to medication and an im-
proved quality of life for TB patients [4,5,21-24]. These
studies emphasized the importance of emotional sup-
port from health providers and supportive networks,
such as neighbors and family, throughout the duration
of TB treatment [4,21,22]. Furthermore, although stu-
dies in both developing and developed countries have
shown that social support can act as a buffer to stress
for patients and help in their recovery, certain interactions
can also result in feelings of isolation and distance within
relationships [25,26].
This study seeks to explore, qualitatively and from the
patient’s perspective, the role of social support during in-
dividuals’ TB treatment, including the voices of those
with HIV co-infection and parents of pediatric patients.
Specifically, the primary objectives of this study are to:
1) explore the types of social support that TB and TB/
HIV co-infected patients in Lima experience during TB
treatment, with a particular focus on its role in the pa-
tient’s psychosocial wellbeing, and possible implications
on treatment adherence; and 2) explore, from the pa-
tients’ perspective, ways in which the Peru TB program
could be improved in terms of providing social support
and other non-clinical services. Because we were inter-
ested in learning about TB patients’ experience of social
support and psychosocial wellbeing during treatment,
and hearing about it in their own words, we chose to ex-
plore this topic in a qualitative manner, using open-
ended semi-structured questions. These findings can
guide the development of interventions for patients’
families, caregivers, and health providers, which ulti-
mately could lead to improved patient wellbeing, and in
turn, more successful treatment outcomes.
Methods
Using semi-structured interview guides, 43 in-depth
interviews were conducted in 2004 and 2005 with
adults in the process of receiving DOTS treatment for
TB (n = 27) and parents of children receiving treatment for
TB (n = 16); of these individuals, there was a sub-group that
were co-infected with HIV (adults, n = 8; children, n = 3).
Four similar interview guides were created, one for
each sub-population (TB, TB/HIV, parent of pediatric
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same topics: description of the process of being diagnosed;
their knowledge of TB (and HIV for TB/HIV cases);
their feelings throughout the process of learning about
and accepting the TB diagnosis; the types of interac-
tions they had or would have liked to have with health
care providers, family and friends associated to their
TB treatment and recovery; how their interactions with
loved ones changed during the course of their treat-
ment; what helped them continue their treatment for
TB; and what suggestions they had for obtaining the
type of support they would have liked from family,
friends, and providers. The interviews took approxi-
mately one to one and a half hours.
Setting
This study took place in Lima, Peru (estimated popula-
tion 8,350,000) [27]. Lima is divided into five main
health regions: participants were recruited from 5 health
centers and the regional hospital in the southern region
of the city (DISA-South estimated population 2,105,296).
Parents of TB and TB/HIV patients were recruited from
the same health centers, as well as from the Instituto
Nacional de Salud del Niño (the Peruvian Children’s
Hospital). All TB patients were enrolled in DOTS ther-
apy, which required that they be observed taking their
TB medications by a healthcare professional at their re-
spective health center.
Sampling, recruitment, and sample size
Purposive sampling was used to select people that would
be able to provide specific knowledge about social
support associated with diagnosis and treatment for TB
in Lima [28]. Our sampling criteria included adults,
both male and female, who were in current treatment
for TB – whether “only” with TB or co-infected with
HIV – or parent of a child in treatment for TB – again,
whether only with TB or co-infected with HIV. We hypoth-
esized that people with co-infection might be dealing with
additional emotional or stigma issues compared to those
with TB. We also hypothesized that this group might have
different types of resources available to them, and therefore,
wanted to hear about the experience of this particular sub-
group. We also focused on individuals who were currently
in treatment, and who had been in treatment for at least
several weeks to give us a broader perspective on their
emotions and social support at different phases of the treat-
ment process. Two psychologists working in the national
TB program in clinics in DISA-North were trained for two
weeks by the PI (VPS), a Peruvian social scientist, to con-
duct the interviews in the above-mentioned health facilities
in DISA-South. Training consisted of reviewing the goals of
the study, practicing the interviews with the PI or with
the PI observing and providing feedback, and finally,the PI was present at approximately eight of the initial in-
terviews of each assistant, and would listen to the tapes of
the interviews as they arrived. Participants were recruited
through clinician gatekeepers. Medical personnel briefly
described the study to adult patients and parents of
pediatric patients who came in for TB treatment. Those
interested in participating were then introduced to one of
the research assistants, who described the study in greater
detail and completed the informed consent process. Re-
search assistants arranged for some to be interviewed in
private locations in the health facility, others at their
homes at a later time. Written informed consent for the
interview and for being audio-recorded was obtained from
all study participants prior to the interview.
In studies with non-probabilistic sampling such as this
one, saturation, defined as the point at which no new
themes or information emerges during the data collec-
tion, is a commonly used threshold for sample size [29].
By the end of the interview process we had reached sat-
uration regarding the main topic of interest: the feelings
experienced and the description of the types of social
support that were helpful and hurtful.
Data analysis and management
All tape recordings were transcribed; codes were then
developed based on the topics of interest that emerged
from the transcripts. Transcripts were then re-read
and coded and analyzed both manually and using
ATLAS.ti [30]. We present the results associated with
social support that emerged, using representative quotes
when appropriate.
Ethical conduct of research
Prior to initiating this study, approval was obtained from
the Institutional Review Boards of Tulane University
School of Public Health and Tropical Medicine and from
three local review boards: Peru’s Instituto Nacional de
Salud del Niño, DISA-Sur authorities, and the Asociación
Benéfica PRISMA (a local non-governmental organization).
Results
Overall, participants report that social support from
their family members and healthcare providers was crucial
toward their psychosocial wellbeing and motivated them
to adhere to their treatment; despite this, many patients
described feeling depressed or even suicidal because of
their diagnosis. Due to stigma related to TB in the com-
munity, few patients revealed their diagnosis outside their
family or closest friends. Regarding programmatic im-
provements for the TB program, patients recommended
improving health education for patients and family,
expanding specialized support to children co-infected with
HIV, and offering additional economic support in the
form of food or job assistance to affected patients.
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Respondents tended to be very selective about which
people in their lives they would tell that they or their
children are TB or TB/HIV positive. Many participants
described a fear of being isolated when diagnosed and
expected that others might avoid them after hearing
about their diagnosis, and as a result, some chose not to
tell their friends or family members. Over half of respon-
dents limited their disclosure to a close circle of entrusted
family, and very few respondents (4/43) showed willing-
ness to disclose to members of the community at large
such as teachers, neighbors, or colleagues (See Table 1).
Role of family
Despite fears regarding alienation or isolation from loved
ones, all but two participants did disclose their disease
status to all or part of their families, and in response, the
majority received abundant love, encouragement, finan-
cial assistance, and other forms of psychosocial support.
About half of all participants discussed the value of the
emotional support provided by their families, mainly in
the form of encouragement that lifted their spirits, and
in several cases, gave them a “reason to live”. One man
with TB/HIV describes how his mother would encourage
him to exercise and eat, and adds: “This is what made
me get up each day.”
Family members reminded patients to go to the clinic
to take their pills and often accompanied them there.
Since the nausea and fatigue associated with the medica-
tion tended to make patients lose their appetite, family
members countered this by cooking for them or making
their favorite dishes. When comparing the amount of
family support received by gender, men—particularly
single men—talked about receiving psychosocial support
from their families more frequently than females did.
Numerous participants also talked about the economic
assistance they received from their families, and in fewer
cases, from friends. Although TB patients receive medi-
cations and tests for free through the Peruvian TB Pro-
gram, they described certain tests and medical-related
costs that were not covered. Some study participants
had to stop working or work much less, and this, com-
bined with the additional costs associated to the disease,
would have been difficult to bear without their family’sTable 1 Disclosure of TB and TB/HIV positive patients
TB adult (n = 19) TB/HI
Told nobody – –
Only family 8 5
Family & friends 8 3
Other community (work, neighbor, teacher, etc.) 2 –
*No information 1 –
*The question was not addressed in the interview.support, which came in the form of childcare, transpor-
tation, and food.
A few isolated cases received negative reactions from
family members. Two TB/HIV positive participants de-
scribed feeling hurt by comments from family members
insinuating they must have had sex with other men or
sex workers to contract this disease. Another patient,
who was in treatment for TB with her child, described
her sister’s distancing words and actions: reminding
other family members they were contagious and to avoid
sharing eating utensils with them, and not letting her
nephews and nieces play with the patient's child. Often-
times, however, family networks were extended and
multi-generational, and if certain members of the family
reacted negatively, others would still offer support.
Regarding relationships between partners and spouses,
almost all adult patients with TB expressed receiving
consistently positive support from their partners, with
significantly more females than males noting the import-
ance of the psychosocial support they received from
their partners. There was a marked difference in the
number of break-ups observed among participants who
were co-infected with TB/HIV and mothers of children
with TB/HIV compared to those who were only diag-
nosed with TB. Several of those co-infected stated that
learning of their HIV diagnosis led to the termination of
their relationships. During confrontation with their part-
ners about their HIV status, some of the co-infected
learned they had been misled or lied to by partners who
knew they were infected with HIV, but had not told
them, leading to their becoming seropositive and in
some cases, transmitting HIV to their children.
Role of healthcare providers
The vast majority of participants described very support-
ive interactions with their health care providers, who in-
cluded doctors, nurses, health promoters, psychologists
or nutritionists. These interactions ranged from encour-
aging words (e.g., encouragement to eat or to keep taking
medications), to being treated with compassion and affec-
tion. Patients appreciated that healthcare providers—nurses
particularly—would give hugs, make jokes, and were not
“afraid” to touch them or speak at close range to them.
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continue treatment since they looked forward to seeing
a cheerful nurse or, as in the case of one participant
who had not told her friends and family, someone to
talk to. Nurses tended to be known most familiarly by
patients, and were often described affectionately and
by name in the interviews.
Additionally, participants noted the importance of
feeling that the provider understood their perspective,
including their fears and concerns; not surprisingly, this
sense of being understood led participants to open up
more with their providers, as the following words of a
young female participant with TB illustrate:
“So Rosaa, who is a very happy nurse, youthful, gives
you the feeling you can ask her anything. Doctor
Sancheza is a more serious doctor who I do not think
cares as much about her patients as Rosa. With
Doctor Sanchez it was like you go, take your pills, and
that’s that. But with Rosa … you can stay hours asking
her questions, talking to her, she asks you how you
have been; it is like that always with her. There is a
constant concern from her… Doctor Sanchez would
attend you and then tell you goodbye. Instead Rosa,
she gets more involved in your life. The patients are
more important to her…”
However, a handful of patients also spoke of interac-
tions with providers that were hurtful and demoralizing.
Within our sample these comments happened to all be
directed specifically at doctors (as opposed to nurses or
other healthcare workers) who were described as “too
serious” or “cold” to the point that some patients be-
came uncomfortable or frightened to return for further
consultations, or in the case of one patient, she did not
take her family for sputum samples as requested by the
doctor, in fear they would be “screamed at” like she had
been by her doctor. Patients who expressed being fearful
or intimidated by their doctors usually were able to
switch doctors and found someone who was a better
match for them, and in fewer cases patients sought care
at a different facility.
In addition to providing key psychosocial support and
encouragement, healthcare providers also played a cru-
cial role in educating patients about what causes TB in-
fection and the details of the treatment process. About
half of the participants appreciated receiving information
from their providers about their disease and what they
could expect at different stages of their treatment.
Clinics hosted regular health education seminars for pa-
tients experiencing TB infection, which appeared to be
well received and well-attended by participants; some
patients repeatedly mentioned that this information was
a significant component of their treatment and recovery.Mental health
At the time of their diagnosis, a large proportion of par-
ticipants expressed feelings of depression, loneliness, and
concern for what the future might bring to themselves
and their families. When deciding whom to disclose
their disease status to, roughly one third of participants
expressed a fear of abandonment from family members,
friends, and partners. Some had become isolated within
their existing social support networks, particularly those
who felt they could not talk openly about their illness
with family and friends. Some, advised by doctors not to
work while on treatment, expressed feelings of anxiety
related to their lack of income during that time.
Numerous participants highlighted that upon receiving
their diagnosis as TB or TB/HIV positive, they were not
aware of the availability of free treatment, and thus ini-
tially thought that they would die from their illness.
Others were psychologically overwhelmed by the many
life changes that were necessary for successful recovery:
the feeling that they were becoming a burden to their
families, the need for frequent trips to the neighborhood
clinic to take pills, and suffering the debilitating affects
of their medications. Four of the participants expressed
that they considered taking their own lives after receiv-
ing their TB diagnosis. As one 24-year-old male de-
scribes: “I even thought about killing myself; the idea
passed through my head. Thank God I got treatment
from the psychologist and that helped a lot… Every time
I saw someone, I thought it would be the last time I
would see them."
Many participants expressed the desire to see the
psychologist more often. They stated that the program
allowed them one visit with the psychologist at the be-
ginning of their treatment, with one monthly visit there-
after, but that this was not sufficient. The poverty of this
allowance seems quite obvious: emotions vary as one
goes through the treatment.
Parents of pediatric TB and TB/HIV patients were
often infected themselves with TB and/or HIV, and thus
were confronted with the double burden of providing
care for their children while simultaneously coping with
the physical and psychological aspects of their own ill-
ness. Some mothers expressed feeling guilty for their
children’s illness; in the case of HIV, for having infected
their child though vertical transmission; in the case of
TB, for not having fed their child well enough to avoid
active TB infection.
Evolving social networks
Our findings indicate that the diagnosis and treatment
of the participants’ illness often changed their social
habits. For a variety of reasons, roughly one third of par-
ticipants reported that they had increasingly withdrawn
from their existing social networks since their diagnosis.
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socialize frequently out of fear of infecting others, or fear
that members in their community would notice that they
appeared ill. Others mentioned that the medications
made them feel so queasy and tired that they no longer
felt like going out in public. A number of TB positive
men, for example, mentioned that they used to play soc-
cer and then drink beer with their friends, but during
treatment had no energy for soccer and were not
allowed to drink alcohol, so as a result they saw their
friends significantly less.
Despite participants’ description of increased social
isolation, an overwhelming majority of adult TB patients
expressed having made valuable new friendships with
other patients in their treatment program with whom
they could discuss their illness openly and feel supported
by. Although structured social support was not available
for TB patients through the clinics, participants noted
that they regularly saw their fellow patients when com-
ing to the clinic to take their pills or to attend a health
education session, and bonded with them through their
interactions at the clinic. Parents of pediatric patients
described meeting other parents at the health education
sessions and striking up mutually supportive friendships.
In addition, the healthcare personnel, particularly nurses,
were often described as having become important new
friends in the eyes of patients. When one 18-year-old TB
positive female was asked whether she had made any
new friends since her diagnosis she replied:
“Yes, everyone in the program, we are already friends.
Everyone—the doctors, the nurses, and everyone that
is around the clinic—they greet me, ask me how I’m
doing, they tell me that I look healthier, so I think we
are all friends; everyone who works, and everyone that
is in treatment…”
In the case of patients with TB/HIV co-infection, the
organized opportunities for patients to receive social
support are even more plentiful. There are health facility
sponsored support groups and several described new
friends whom they met during the group time, as well as
at other times including weekends to socialize. In con-
trast, there are no facility sponsored support groups for
TB patients, which was something that several TB pa-
tients noted that they would like to have available to
them. They noted that having a space where patients
can express their feelings and struggles would be benefi-
cial to all to have an outlet to socialize and feel they are
“not alone” by organizing social events.
Perceived stigma
Nearly all participants acknowledged the existence of
negative stigma surrounding TB and TB/HIV infectionpresent in the community. The perceived stigma
manifested itself in a variety of forms, but most com-
monly, participants expressed feelings of embarrassment
of having an illness that is highly contagious, fearing that
people will want to distance themselves. Despite the fact
that drug-susceptible TB patients who have taken appro-
priate TB medications for six weeks or more are virtually
non-contagious [14], there was a strong stigma attached
to being treated for TB. Many participants expressed that
they were initially embarrassed to be seen going to the
clinic to take TB medication, and some sought out treat-
ment at a facility that was located further from their home
in order to avoid being seen. Mothers of pediatric patients
consistently described a desire to protect their children
from the stigma they might encounter from peers or the
wider community by only disclosing to a select group of
trusted friends or family. Only 2 out of 13 mothers of
pediatric TB patients informed the children’s school that
their child was infected with TB. Moreover, about half of
the mothers described guilt about their child’s TB diagno-
sis, feeling that insufficient care or nutrition had led to
their child’s illness. Multiple participants commented that
TB is often referred to as a “sickness of the poor” and that
many people in the community who are not well educated
about TB perpetuate this and other negative stereotypes.
One example of stigma in the community came from the
mother of a child who has TB. She described feeling stig-
matized by her own church Bishop, who upon finding out
that her child was infected with TB, banished them both
from attending church until the child was healthy again.
When those co-infected with TB and HIV were asked
to compare the extent of stigma that exists around TB
versus HIV, they felt the stigma for HIV patients is
somewhat stronger. Some mentioned their perception of
this increased stigma for HIV versus TB is in part that
HIV is more closely associated with death, and others
explained HIV’s implicit association with homosexuality
in the community. A 33-year-old HIV positive man ex-
plains: “With HIV it’s different, people in the street start
to make mean comments about you that are out of con-
text; they call you a faggot. This is why I prefer not to
tell other people.”
Within the clinical setting, participants noted that lon-
ger wait times might deter those patients who are
embarrassed or scared that someone will see them from
continuing treatment: one young man describes how he
would arrive daily to the clinic, look around for anyone
he might know before going to the waiting area, and if
he did see someone who knew him, how he would hide
elsewhere until no one might recognize him. Participants
also complained about the lack of privacy. As one 22-
year-old male with TB describes, “There should be a
room, not an exposed [open] room where people can
see you, because it is always embarrassing. More than
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pills when everyone can see them.”
Participants’ Recommendations to improve TB programs
Participants mentioned improvements needed in the
following areas: 1) Health education for patients; 2)
Special needs of children with TB and TB/HIV; 3) Health
education for patient families and community; and 4)
Additional programmatic support.
Health education for patients
Several participants suggested that it would be more
effective to provide information to patients in relation to
their phase of treatment. One 18-year-old adult woman
with TB explained:
“Right now the health posts have it wrong. When I go to
pick up my food basket, they talk to us about different
TB concerns. We are about 15 people, and several of us
are about to finish treatment. So they give us talks that
they should have given us at the start of treatment, like
what tuberculosis is. They should separate us into
groups. Those who are just starting should be separate
from those of us who are finishing treatment.”
Related to this, several participants suggested asking
people who had previously been infected with TB to
work as health educators so that they could build posi-
tive relationships with patients and teach them from
their own experiences, i.e., peer educators. One 18-year-
old woman in treatment for TB said: “The former pa-
tient knows what the patient feels like. They know better
than anyone: better than the doctor, better than all.”
Special needs of children with TB and TB/HIV
The parents of children with TB and TB/HIV expressed a
desire to receive more specialized education, counseling
and advice with regard to specifically caring for their chil-
dren. Additionally, parents want health providers who have
certain qualities important for working with children, such
as a personable approach (greeting children with a smile),
having extra patience, making children feel comfortable and
providing a peaceful ambiance. One parent of a child with
TB/HIV recommended that “they should treat a child with
affection, that’s most important, treating them well, showing
them that they will get better, smiling at them.” Some par-
ents felt that a separate facility just for children would be
ideal. Other parents expressed a need for more economic
assistance, more home visits and experienced doctors rather
than student residents to provide these services.
Health education for patients’ families and community
Numerous participants noted the need for increased TB
education to the general public and patients’ families,such as TB campaigns in the media, programs in schools
and outreach to families. A parent of a child with TB
noted, “If I could, I would show a program on the TV or
radio… so that parents can learn what to talk to their
children about if they have this disease and to know how
to prevent this disease.” One 18-year-old female with TB
suggested “community campaigns to teach people what
it is, how it is cured, how to avoid it…” Several partici-
pants stated that educating the youth through their
schools could be an effective vehicle for reaching large
numbers of people, but that the education of TB and
other illnesses must be thorough.
The participants noted the need of specific education
for families and friends of patients so that they can better
understand the dynamics of treatment and the illness.
One adult male with TB stated the need for “explaining at
the very least to the people closest to me what they need
to do to be careful.” Another adult male with TB/HIV
recommended “inviting the family member of a patient
who does not consistently attend his or her medical ap-
pointments to serve as a support for that patient.”
Additional programmatic support
Other recommendations included the provision of
breakfast for people when they come in the morning to
take their medications, more variety in the food given to
the patients as part of the National TB Program, for
food to be given consistently each month, an increase in
the number of home visits, the availability of all services
at the same location, the ability to take medication home
if the facility schedule interferes with work, free consul-
tations with doctors when needed and a vocational train-
ing program. A 33-year-old male with TB/HIV noted
that the National TB Program could do more to help
those who can’t find work: “There are many people who
don’t have work; provide a workshop, to help us in some
type of way. It could be to learn to knit sweaters, make
shoes, carpentry - these skills can help people defend
themselves, because for those with this illness, some-
times people at their work find out and they are fired
and they are left with nothing.”
Discussion
The provision of unique forms of social support (or lack
thereof) from family, caregivers, and the wider community
plays a distinct role in affecting patients’ psychosocial
wellbeing. Outside factors such as poverty, add layers of
complexity to patient psychosocial needs, and thus the
types of programmatic interventions and future research
needed to adequately address them.
Social Support: the role of family, friends & community
Compared to other social groups, families were the most
highly involved group in terms of supporting and caring
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regular encouragement for patients to eat, take their
medications, and maintain a positive outlook. It is inter-
esting to note that the majority of participants who de-
scribed the emotional support and caregiving received
from their family as the most important type of support
were single men, likely receiving it from their mothers
and sisters. Studies on TB and gender denote that
women are often more caring of other members of the
family and continue in the role of caretaker even when
sick. When men and children in the home are sick,
women will prioritize their needs to provide better care
for them [25,31]. Another study from Peru found that
the burden of caring for TB patients tended to fall on
women [32]. A future study that incorporates interviews
with contact cases of TB patients would be an interest-
ing way to understand the caregiving role of women and
how it evolves if they contract the disease themselves.
Regarding partner support, more women than men
expressed the significance of their partners’ involvement;
three-fourths of those who mentioned partner support
were women. Research affirms that women may express
more importance in their husband’s presence and fears
of him leaving them during the sickness because of eco-
nomic dependence [22,25]. It may also be that stereotyp-
ically women are expected to provide this type of
support and thus it is taken for granted by some men.
Health practices must address partner issues that arise
during TB treatment, such as sleeping arrangements
while patient is contagious, and relationship breaks-ups
as a result of disclosure. Further research would be use-
ful in order to understand what actions partners of TB
patients should take to optimally support the psycho-
logical and physical needs of their partner.
In examining the role of social support from the wider
community, we note the enormous potential for mem-
bers of the community to be a valuable source of social
support to patients. The majority of participants did not
tell community members about their sickness due to fear
of discrimination or embarrassment, as has also been
found in other studies [33-36]. Reactions like those of
the Bishop banishing the woman from church contribute
to the fears of many patients with TB, who then do not
tell people beyond their closest network of family and
friends. However, contrary to what many participants
expected, this study found that most of those who
disclosed their status to a wider audience received posi-
tive support and made new friendships as a result of
their disclosure. If structured support groups or associa-
tions were available for TB patients, similar to those
available for HIV patients, they could facilitate support-
ive interactions among TB patients and improve patient
psychosocial wellbeing. Research in other developing
countries has demonstrated that social support groupssuch as “TB clubs” have facilitated a greater understand-
ing of the disease, positive relationships with health
personnel, and a more positive attitude within the com-
munity, resulting in less stigmatization and more com-
munity support [23].
An interesting and unexpected observation from this
study was that patients’ social networks tended to evolve
(vs. diminish or expand) when comparing social habits
and friend groups pre- and post-diagnosis. Roughly one
third of participants reported feeling increased social
withdrawal from their existing social networks after their
diagnosis. Some explained that they felt less sociable
because they were afraid of infecting others or of being
judged by their peers, while others simply felt too phys-
ically ill from their treatment to engage in their regular
social activities. Given the apparent mental health needs
within this patient population, it is likely that feelings of
depression also contributed to social withdrawal. A
woman positive for TB and HIV attributed her initial
social withdrawal to the fact that she was jealous of her
“healthy friends”, then subsequently made new, support-
ive friends who she met while taking TB medications at
the clinic. In the case of this woman, and the other par-
ticipants who similarly left behind their old social net-
works while they focused on their treatment, it would be
interesting to know what long-term implications this
might have on their social life and their psychosocial
wellbeing. Will they rejoin their old friend group eventu-
ally? Likewise, for those who made new friends during
treatment, will they likely keep those friendships in the
long-term after they are cured?
Importance of positive patient-provider interactions
The significance of the patient-healthcare provider rela-
tionship and its influence on the patient’s desire to re-
turn to the health facility or not, as well as the patient’s
trust in their health provider, was a key element in the
results of this study, as has been found in others [22,37].
Certain components of patient-provider communication,
in particular a caregiver’s ability to listen and show re-
spect to their patient, are important determinants of the
patient’s healthcare utilization [38]. Since many patients
exhibited low self-esteem and feelings of social isolation,
the kind words and generally supportive attitude of the
healthcare staff were important factors in encouraging
participants to continue with their treatment in spite of
the physical and psychological difficulties associated with
the treatment process. Given the particular importance
of treatment adherence among TB patients in order to
avoid developing more dangerous drug resistant strains
of TB, it is important that stakeholders in the TB com-
munity understand the potential utility of well-trained
healthcare providers. Regular training and refresher
workshops for healthcare providers that address emotional
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interactions), including basic communication skills, could
be helpful, as requested by the study participants.
The level of healthcare staff motivation and the quality
of their interactions with TB patients is one of seven
types of interventions intended to improve adherence
that is currently being evaluated by the Cochrane
Collaboration [3]. The majority of negative interactions
described between patients and healthcare providers in-
volved doctors who seemed to use fear and intimidation
tactics to scare patients into treatment compliance.
What we found was that those providers who used these
methods to motivate participants to return usually only
discouraged them or led the participants to seek out
other providers or, in a few cases, other facilities for
their care. However, our limited sample focused on indi-
viduals who were in treatment, so we did not capture
patients who had negative treatment outcomes nor the
reasons they had for discontinuing treatment.
TB & poverty: further economic support for this
impoverished population
The need for further economic support from families,
friends and the community also emerged as a recurring
theme from participants in this study. It is inevitable to
discuss the issue of poverty when writing about TB. Pov-
erty is a risk factor in becoming infected with TB, and
results demonstrate that already impoverished families
become further burdened by this stress when dealing
with TB [4,5,22,26,39]. Although Peru’s TB program pro-
vides a food basket and free medications to TB patients
of low socioeconomic status, participants indicated that
they would appreciate further nutritional support, such
as the provision of breakfast at the clinic when coming
to take their pills in the morning. Further economic hin-
drances to completing treatment were described, such as
transportation costs, and costs for required additional
medical treatment, such as X-rays and blood work or
care from other specialized physicians. Some of these
services should be covered, but these are difficult for
some patients to access, which results in patients paying
for them. Because a subset of the study participants was
also co-infected with HIV, it is worth noting that these
patients represent a particularly economically vulnerable
group. TB/HIV patients cope with a lifelong condition
that forces them to manage multiple diseases and/or op-
portunistic infections, often having to seek treatment at
multiple facilities within one day, which can inhibit their
ability to generate income over their lifetime.
Another related issue is that since many TB patients
must leave their jobs during treatment, some get fired as
a result. This loss of income can be devastating not only for
the patient but also to the family that they had previously
been supporting. The incorporation of group incomegenerating activities into the current TB program, as
was suggested by participants, could be a productive
way to both encourage socialization among patients
and contribute to their economic wellbeing.
Depression is common: staged mental health
interventions needed
An important observation from this study for its program-
matic implications was the extent of apparent mental
health needs among the patient population. Participants
consistently expressed the importance of their monthly
psychological consultations in helping them “keep going”
and their desire for the visits to be more frequent. Within
our sample of 43 participants, there were 4 patients
who had considered taking their own life as a result of
their diagnosis. Psychological issues associated with TB
diagnosis have been shown to manifest as a result of
patients’ feelings of fear and guilt of infecting others;
social discrimination, the socio-economic stress and
psychological burdens of living with a life-threatening
illness; increased dependence on others; and concomi-
tant poverty [40]. A 2007 mental health assessment of
rural Lima shows that about 20% of the inhabitants
had ever felt either moderately or severely depressed,
citing poverty and unemployment as the main areas of
preoccupation for this population—no literature was
found on depression rates in peri-urban locations [41].
Several other authors have described how psychosocial
factors such as anxiety and depression can complicate
adherence to drug regimens, and emphasize the im-
portance of attention to mental health needs to ensure
positive treatment outcomes [40]. The mental health
needs of these patient populations are numerous, rele-
vant in terms of treatment outcomes, and perhaps not
being met to the fullest extent.
In this study patient mental health needs appeared to
be highest during the period immediately following their
diagnosis of TB or TB/HIV. During this period, patients
faced a barrage of emotions including shock, embarrass-
ment, and concern for their families. Also during this
initial phase, patients did not have the opportunity to re-
ceive education regarding what to expect in the treat-
ment of their illness and are particularly fearful of what
their future might hold. This period should be recog-
nized as a critical time for educational and psychological
intervention to ensure that patients feel supported to
move forward with their treatment. Again, it is import-
ant to note that our sample consisted only of patients in
treatment (the “success” cases); it would be interesting
to know what proportion of patients who left treatment
could have benefitted from enhanced psychosocial sup-
port following their diagnosis. Programmatically rele-
vant, those at later stages of treatment commented the
need for time-relevant psychological support: patients at
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same counseling.
Interviews with parents of pediatric patients revealed
the difficulties faced by parents who were also infected
with HIV and/or TB in providing care and support for
their children. All mothers of pediatric patients positive
for TB and HIV were HIV positive themselves, and
some parents of TB patients were also being treated for
TB alongside their children. Whilst these parents experi-
enced fatigue and nausea from their own treatment, they
also were forced to find the strength and motivation to
care for their children; feeding them, taking them to the
clinic, and consoling them. Moreover, they communi-
cated their efforts to hide their true emotions of sadness,
frustration, or guilt in order to protect their children
from feeling abnormal or stigmatized.
Patient requested programmatic activities: peer support
and educational opportunities
Several participants expressed a desire for increasing
supportive peer education activities, directed at patients,
to be incorporated into the existing TB program. Peer
support models have indeed been proven as an effective
tool to influence patients’ health-seeking behaviors and
serve as a complement to clinical services, particularly
in the field of HIV education and prevention activities
[42]. Similar to the case of HIV, TB is also an illness that
is clinically complex, manifests itself in various stages,
and is often attached to social stigma, making the need
for patient education and psychosocial support crucial.
The value in peer support is that it empowers patients
to participate in their own healthcare rather than relying
on healthcare professionals to enforce treatment compli-
ance. There has been little published on the potential for
using peer assistance interventions to improve TB pa-
tient education and encouraging medication adherence.
However based on their success in the context of HIV,
as well as the request from our study participants, the
use of peer educators could prove to be a valuable and
cost effective way to supplement clinical care TB in
resource-constrained settings.
Finally, as a recommendation to improve the type of
support and understanding participants wanted from
others, most suggested community-wide TB and HIV
education programs, tailored for various audiences, in-
cluding patients themselves, families, partners and the
wider community. Research demonstrates that receiving
more information on the disease as a patient empowers
the patient to feel more confident and active in his or
her treatment. Likewise, when families and support net-
works are well informed about the treatment process,
patients experience less social isolation [37]. That said,
future research on this topic could focus on questions
like: what role can families play in encouraging patienttreatment adherence? Will patients and families partici-
pate in support groups or will these be avoided due to
possible stigma?
Limitations
Our findings capture certain issues and trends as ob-
served by a small group of people being treated for TB
or TB/HIV, but these are not representative of the gen-
eral population, nor are they meant to be. All of the pa-
tients interviewed were recruited through a health care
provider, were currently in treatment for TB, and were
willing to speak with someone regarding their specific
health situation; there is a clear selection bias. Also,
since participants selected had been in TB treatment for
at least a few weeks, so that we could obtain a broader
perspective on social support issues throughout the
course of their treatment, there could be an issue of re-
call bias regarding emotions or social support at the
earlier phases of treatment. Although the recruitment
process for pediatric patients targeted patients under the
age of 12, the exact age of pediatric patients whose par-
ents were interviewed was not recorded. Due to our
sampling design, we did not speak with any patients who
had stopped receiving treatment, yet this would be a
particularly important group of people to interview in
future research. Finally, the focus of this research was on
social support during treatment for TB, and though we
included individuals with HIV co-infection, we did not
probe on specifics about people’s HIV treatment or
managing their health care needs associated to both
diseases—yet there is obviously much more to be
learned from this sub-group. We also did not find out
about the stage of their HIV disease, which is particu-
larly relevant since we observed evolving issues related
to their mental health and social support after diagnosis
with TB, and would expect similar changes at different
stages of HIV disease.
Conclusion
Various types of support play a significant role in pa-
tients’ recovery and treatment outcomes, and although
the family is a key social support provider, it is clearly
not the only support system that can be tapped into.
Families, friends, and healthcare providers all contrib-
uted to the patients’ support system in different ways,
but as expressed by patients themselves, educational
programs targeting these different groups would enable
them to better support the patients. Patient-provider
interactions were described as overwhelmingly positive,
which likely contributed to improved patient psycho-
social wellbeing. Perceived stigma in the community,
lack of psychosocial support, and forced lifestyle changes
associated with TB and TB/HIV positive diagnosis con-
tribute to the significant mental health needs of this
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port to help patients cope with anxiety, depression, and
frustration associated with their TB diagnosis may cause
a reduction in patient quality of life and lead to de-
creased treatment adherence. To meet patient psycho-
social needs and to improve the Peru TB program
overall, participants made valuable suggestions which
should be considered in future development of TB sup-
port programs: extending disease-specific educational
opportunities to patients’ families and the wider commu-
nity; increasing the existing amount of nutritional sup-
port; program provision of vocational activities to
increased economic opportunities; and increased fre-
quency of psychological counseling. Future research on
the topics of the evolving social networks of TB patients,
links between mental health needs and treatment adhe-
rence levels, staged implementation of patient psycho-
logical support, and the quantification of TB stigma
would be useful contributions to this field. Bridging the
gaps that remain among communities, families, patients
and health providers through training, health education
and improved communication could ensure a healthier,
more informed population that is better equipped to
provide social support to individuals who need it.
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